• International Myeloma Workshop 2015 Meeting Highlights
  • Read Today
  • Risk Stratification Strategies
  • ASH 2015 Booth
  • New Paradigms and Emerging Frontiers: The Immunotherapy Revolution in Multiple Myeloma
  • Meeting Highlights in Multiple Myeloma From the 2015 European Hematology Association Annual Congress
  • Clinical Discussion Series
  • Are You One in a Million
  • ASCO 2015 Meeting Highlights
  • Clinical Dialogues™ in Multiple Myeloma

What's New

CE Activity
Practice Essentials
The Importance of Establishing Baseline Disease Characteristics in Myeloma Diagnosis and Management
Kenneth C. Anderson, MD, and Brian G.M. Durie, MD
Managing Myeloma Regimen Protocol Series
Practical, hands-on guides that summarize the safe and effective use of new regimens in multiple myeloma
CE Activity
Annual Meeting HighlightsInternational Myeloma Workshop 2015 Meeting Highlights
Sergio A. Giralt, MD, FACP; Sundar Jagannath, MD; Shaji K. Kumar, MD; Sagar Lonial, MD; Noopur Raje, MD; Joshua Richter, MD
CE Activity
Practice Essentials
New Strategies in Relapsed/Refractory Myeloma: Translating Data into Clinical Practice
Ajay K. Nooka, MD, MPH, FACP, and Saad Z. Usmani, MD, FACP
Shifting Paradigms e-Monograph – This accredited e-monograph summarizes key proceedings from a live symposium originally held at the 20th Congress of the European Hematology Association in Vienna, Austria. - Read Now
European Medicines Agency Accepts Ixazomib's Marketing Authorization Application for Patients with Relapsed/Refractory Multiple Myeloma
Missed out on this year’s EHA meeting in Vienna? We have you covered! – Slides from our live satellite symposium in Vienna, Austria - Shifting Paradigms in Multiple Myeloma: Future Insights to Practice

Revised International Staging System for Multiple Myeloma has Been Made Available: As Discussed in a Report From the International Myeloma Working Group (IMWG) published in the Journal of Clinical Oncology.
PubMed Abstract  Journal Link

Takeda Submits New Drug Application for Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma
CE Activity
Clinical Discussion SeriesSelecting Patients for Maintenance or Continuous Therapy Including Regimen Selection and Duration of Treatment with Philip McCarthy, MD and
Multiple Myeloma Response Assessment and Tailoring Therapy with Edward A. Stadtmauer, MD
Risk Stratification Strategies Series
Managing Myeloma Risk Stratification Strategies for Multiple Myeloma Series
In this important two-part series, leading clinical experts in myeloma, Dr. Sagar Lonial and Dr. Noopur Raje, provide insight and practical guidance for risk stratifying high-risk myeloma patients.
FAQ Library
Dr. Ajay K. Nooka, Dr. Saad Z. Usmani, and Dr. Philip L. McCarthy answer new FAQs
Journal Club Library
Four recent abstracts with associated “Impact on Practice” are provided.
CE Activity
Annual Meeting HighlightsEHA Annual Meeting Highlights 2015 Live: Advances in Multiple Myeloma Treatment and Management
Sagar Lonial, MD; Paul G. Richardson, MD; Nikhil Munshi, MD; Antonio Palumbo, MD
CE Activity
Annual Meeting HighlightsASCO 2015: Highlights in Multiple Myeloma
Meletios A. Dimopoulos, MD; Sagar Lonial, MD; Donna E. Reece, MD; and Edward A. Stadtmauer, MD
CE Activities
Practice Essentials

Seeking Enhanced Management Strategies for Newly Diagnosed, Transplant-eligible Multiple Myeloma Patients
Paul G. Richardson, MD
Optimizing Outcomes in Multiple Myeloma: New Regimens and Sequencing Strategies for the Individual Patient
Robert Orlowski, MD, PhD